期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

受体选择性维甲酸类药物的抗角化应用 被引量：1

原文传递
导出
摘要 维甲酸类药物因其抗角化作用,在白斑和扁平苔藓等角化异常疾病中得到广泛应用。然而由于常规的维甲酸类药物选择性低,长期应用有较多的毒副作用。本文对维甲酸类药物进行综述,并介绍一种新的受体选择性维甲酸类药物,以期为抗角化治疗提供参考。
作者 李庆福 白倩 周红梅
机构地区 四川大学华西口腔医院黏膜科
出处 《临床口腔医学杂志》 2009年第1期55-57,共3页 Journal of Clinical Stomatology
关键词 受体选择性 维甲酸 抗角化
分类号 R781.5 [医药卫生—口腔医学]
  • 相关文献

参考文献10

  • 1张石革,宋菲.维A酸受体药物的研究回顾及皮肤临床应用的评介[J].中国医药导刊,2002,4(3):189-192. 被引量：4
  • 2Scardina GA, Garini F, Maresi E, et al. Methods Find Exp Clin Pharmacol [J]. 2006,28 (2) : 115-119.
  • 3Scardina GA, Messina P, Carini F, et al. A randomized trial assessing the effectiveness of different concentrations of isotretinoin in the management of lichen planus[J]. Oral Maxillofac Surg, 2006, 35 (1): 67-71.
  • 4Weindl G,Roeder A,Schafer-Korting M,et al. Receptor-selective retinoids for psoriasis: focus on tazarotene [J]. American Journal of Clinical Dermatology, 2006, 7 (2): 85-97.
  • 5Bayramguler D, Apaydin R, Bilen N, et al. Limited benefit of topical calcipotriol in lichen pianus treatment: a preliminary study [J]. Dermatol Treat, 2002, 13 (3) : 129-132.
  • 6Pacheco A,Kerdel F. Successful treatment of lichen planus with lowmolecular-weight heparin:a case series of seven patients [J].Dermatol Treat, 2001, 12 (2) : 123-126.
  • 7Edwards KR, Burke.WA. Treatment of localized discoid lupus ervthematousus with tazarotene [J]. Am Acad Dermatol, 1999,41 (6): 1049-1050.
  • 8Petruzzi M,De Benedittis M,Grassi R,et al. Oral lichen planus:a preliminary clinical study on treatment with tazarotene[J]. Oral Dis, 2002, 8 (6) : 291-295.
  • 9陈晓莉,方红.他扎罗汀的临床应用进展[J].国外医学（老年医学分册）,2006,27(5):193-196. 被引量：2
  • 10Yen A,fenning R, Chandraratna R, Mol Pharmacol, et al. A retinoic acid receptor beta / gamma-selective prodrug (tazarotene) plus a retinoid Xreceptor ligand induces extracellular signal-regulated kiactivation, retinoblastoma hypophosphorylation, Goarrest, and cell differentiation [J]. Mol Pharmacol, 2004,66 (6) : 1727-1737.

二级参考文献22

  • 1涂彩霞,郭伟,崔春华,程旭光,林熙然.Tigason治疗泛发性脓疱型银屑病[J].中华皮肤科杂志,1996,29(2):129-129. 被引量：3
  • 2Taar M, EUer MS, Gilchrest BA. Fifty years of skin aging. J Invest Dermatol Symp Proc, 2002; 7:51 -58
  • 3Phillips TJ, Gottilieb AB, Leyden JJ et al. Efficacy of 0. 1% tazarotene cream for the treatment of photodamage:A 12 -month multicenter, randomized trial. Arch Dermatol, 2002; 138:1486-1493
  • 4Chtinger LA, Kaidbey K, Lim J et al. Histological affects of tazarotene 0. 1% cream vs. vehicle on photodamaged skin : a 6 - month, muhicenter, double - blind, randomized, vehicle- controlled study in patients with photodamaged facial skin. Br J Dermatol, 2004; 151:1245 -1252
  • 5Diepgen TL, Mahler V. The epidemiology of skin cancer.Br J Dermatol, 2002 ; 146 : 1 - 6
  • 6Bianehi L, Orlandi A, Campione E et al. Topical treatment of basal cell carcinoma with tazarotene : a elinieopathological study on a large series of cases. Br J Dermatol,2004; 151:148 - 156
  • 7Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol, 2000; 43:31 -35
  • 8Apisamthanarax N, Talpur R, Ward Set al. Tazarotene 0. 1% get for refractory mycosis fungoides lesions : an open -label pilot study. J Am Acad Dermatol, 2004; 50: 600 - 607
  • 9Phillips TJ. An update on the safety and efficacy of topical retinoids. Cutis, 2005 ; 75 : 14 - 22
  • 10Nagpal S, Chandraratna RAt. Recent developments in receptor - selective retinoids. Curr Pharm Des, 2000 ; 6 :919 -931

共引文献4

同被引文献1

引证文献1

临床口腔医学杂志
2009年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部